Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma

Pancreas

Volumn 38, Issue 8, 2009, Pages 968-976

  Welsch, Thilo ^a   Keleg, Shereen ^a   Bergmann, Frank ^a   Bauer, Sonja ^a   Hinz, Ulf ^a   Schmidt, Jan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Actin; AlphaYactinin 4; Invadopodia; Pancreatic cancer; Prognostic marker

Indexed keywords

ACTIN; PROTEIN ACTININ 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH NODE METASTASIS; METASTASIS; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; STAINING;

ACTININ; AGED; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 70350633830     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181b28d6f     Document Type: Article

References (26)

1. Pogue-Geile KL, Chen R, Bronner MP, et al. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 2006;3:e516.
2. Slater E, Amrillaeva V, Fendrich V, et al. Palladin mutation causes familial pancreatic cancer: absence in European families. PLoS Med. 2007;4:e164.
3. Zogopoulos G, Rothenmund H, Eppel A, et al. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Hum Genet. 2007;121:635-637.
4. Welsch T, Endlich K, Giese T, et al. Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization. Cancer Lett. 2007;255:205-218.
5. Goicoechea S, Arneman D, Disanza A, et al. Palladin binds to Eps8 and enhances the formation of dorsal ruffles and podosomes in vascular smooth muscle cells. J Cell Sci. 2006;119:3316-3324.
6. Ronty M, Taivainen A, Moza M, et al. Molecular analysis of the interaction between palladin and alpha-actinin. FEBS Lett. 2004;566: 30-34.
7. Welsch T, Endlich N, Kriz W, et al. CD2AP and p130Cas localize to different F-actin structures in podocytes. Am J Physiol Renal Physiol. 2001;281:F769-F777.
8. Honda K, Yamada T, Endo R, et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol. 1998;140:1383-1393.
9. Yamamoto S, Tsuda H, Honda K, et al. Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type. Mod Pathol. 2007;20:1278-1285.
10. Barbolina MV, Adley BP, Kelly DL, et al. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Lab Invest. 2008;88:602-614.
11. Fu L, Qin YR, Xie D, et al. Identification of alphaYactinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer. 2007;110:2672-2681.
12. Honda K, Yamada T, Hayashida Y, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology. 2005;128:51-62.
13. Kikuchi S, Honda K, Tsuda H, et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res. 2008;14:5348-5356.
14. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
15. Welsch T, Kleeff J, Friess H. Molecular pathogenesis of pancreatic cancer: advances and challenges. Curr Mol Med. 2007;7:504-521. (Pubitemid 47244895)
16. Goffart S, Franko A, Clemen CS, et al. alphaYActinin 4 and BAT1 interaction with the cytochrome c promoter upon skeletal muscle differentiation. Curr Genet. 2006;49:125-135.
17. Kaplan JM, Kim SH, North KN, et al. Mutations in ACTN4, encoding alphaYactinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000;24:251-256.
18. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis. 2006;23:97-105.
19. Hayashida Y, Honda K, Idogawa M, et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res. 2005;65: 8836-8845.
20. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007; 1773:642-652.
21. Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651-1660.
22. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199-1210.
23. Bouwens L. Cytokeratins and cell differentiation in the pancreas. J Pathol. 1998;184:234-239.
24. Cao D, Maitra A, Saavedra JA, et al. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod Pathol. 2005;18:752-761.
25. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610-618.
26. Yekebas EF, Bogoevski D, Cataldegirmen G, et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg. 2008;247:300-309.